ICU Medical EBITDA Margin 2010-2025 | ICUI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICU Medical (ICUI) over the last 10 years. The current EBITDA margin for ICU Medical as of March 31, 2025 is .
| ICU Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $2.42B | $0.29B | 11.86% |
| 2024-12-31 | $2.38B | $0.27B | 11.34% |
| 2024-09-30 | $2.34B | $0.23B | 9.62% |
| 2024-06-30 | $2.30B | $0.24B | 10.50% |
| 2024-03-31 | $2.26B | $0.24B | 10.68% |
| 2023-12-31 | $2.26B | $0.26B | 11.47% |
| 2023-09-30 | $2.25B | $0.27B | 12.18% |
| 2023-06-30 | $2.29B | $0.25B | 10.94% |
| 2023-03-31 | $2.31B | $0.26B | 11.45% |
| 2022-12-31 | $2.28B | $0.23B | 9.91% |
| 2022-09-30 | $2.04B | $0.21B | 10.33% |
| 2022-06-30 | $1.78B | $0.21B | 11.90% |
| 2022-03-31 | $1.54B | $0.19B | 12.32% |
| 2021-12-31 | $1.32B | $0.21B | 16.25% |
| 2021-09-30 | $1.30B | $0.22B | 16.67% |
| 2021-06-30 | $1.28B | $0.20B | 15.48% |
| 2021-03-31 | $1.26B | $0.19B | 14.76% |
| 2020-12-31 | $1.27B | $0.18B | 14.48% |
| 2020-09-30 | $1.27B | $0.17B | 13.18% |
| 2020-06-30 | $1.26B | $0.18B | 14.18% |
| 2020-03-31 | $1.26B | $0.18B | 14.56% |
| 2019-12-31 | $1.27B | $0.19B | 14.61% |
| 2019-09-30 | $1.29B | $0.16B | 12.71% |
| 2019-06-30 | $1.31B | $0.13B | 10.00% |
| 2019-03-31 | $1.36B | $0.13B | 9.65% |
| 2018-12-31 | $1.40B | $0.10B | 7.43% |
| 2018-09-30 | $1.43B | $0.16B | 10.92% |
| 2018-06-30 | $1.45B | $0.15B | 10.31% |
| 2018-03-31 | $1.42B | $0.08B | 5.79% |
| 2017-12-31 | $1.29B | $0.05B | 4.18% |
| 2017-09-30 | $1.02B | $0.01B | 0.98% |
| 2017-06-30 | $0.77B | $0.02B | 3.10% |
| 2017-03-31 | $0.54B | $0.07B | 12.83% |
| 2016-12-31 | $0.38B | $0.10B | 27.11% |
| 2016-09-30 | $0.37B | $0.10B | 27.27% |
| 2016-06-30 | $0.36B | $0.10B | 28.37% |
| 2016-03-31 | $0.35B | $0.10B | 28.86% |
| 2015-12-31 | $0.34B | $0.09B | 26.10% |
| 2015-09-30 | $0.33B | $0.09B | 26.59% |
| 2015-06-30 | $0.32B | $0.07B | 22.67% |
| 2015-03-31 | $0.32B | $0.06B | 19.56% |
| 2014-12-31 | $0.31B | $0.06B | 19.42% |
| 2014-09-30 | $0.31B | $0.06B | 20.20% |
| 2014-06-30 | $0.31B | $0.07B | 22.04% |
| 2014-03-31 | $0.31B | $0.07B | 22.68% |
| 2013-12-31 | $0.31B | $0.07B | 23.25% |
| 2013-09-30 | $0.32B | $0.08B | 24.45% |
| 2013-06-30 | $0.32B | $0.08B | 25.24% |
| 2013-03-31 | $0.32B | $0.08B | 26.35% |
| 2012-12-31 | $0.32B | $0.08B | 26.18% |
| 2012-09-30 | $0.31B | $0.09B | 29.03% |
| 2012-06-30 | $0.31B | $0.09B | 27.87% |
| 2012-03-31 | $0.31B | $0.09B | 27.78% |
| 2011-12-31 | $0.30B | $0.09B | 28.24% |
| 2011-09-30 | $0.30B | $0.07B | 24.41% |
| 2011-06-30 | $0.30B | $0.07B | 24.75% |
| 2011-03-31 | $0.29B | $0.07B | 24.48% |
| 2010-12-31 | $0.28B | $0.07B | 22.97% |
| 2010-09-30 | $0.28B | $0.06B | 21.74% |
| 2010-06-30 | $0.25B | $0.05B | 20.87% |
| 2010-03-31 | $0.24B | $0.05B | 21.43% |
| 2009-12-31 | $0.23B | $0.05B | 23.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.252B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |